Europe In-Vitro Diagnostics Market Forecast to 2030
Europe In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rise in the Demand for In-Vitro Diagnostics During COVID-19 Pandemic Fuels Europe In-Vitro Diagnostics Market
IVDs that are used in the diagnosis of infectious diseases include immunoassays, and molecular assays. Diagnostics companies also focus on making rapid advancements in their offerings to manage COVID-19. Further, regulatory authorities introduced temporary amendments or modifications to their standards, which favored the launches of new IVDs during the pandemic. The demand for molecular diagnostics and immunoassays surged due to these government initiatives. Moreover, many companies expanded their product lines for IVD manufacturing.
In June 2021, the British In Vitro Diagnostics Association (BIVDA) launched “The Digital Revolution” strategy to encourage breakthroughs in in-vitro diagnostics during the COVID-19 pandemic. In July 2022, BioGX announced the launch of a CE-marked, three-gene point-of-care (POC) multiplex COVID-19 test on its Pixel platform. Thus, the COVID-19 pandemic has benefitted the in-vitro diagnostics market due to the rising demand for point-of-care (POC) diagnostics and laboratory testing procedures.
Europe In-Vitro Diagnostics Market Overview
The Europe in-vitro diagnostics market has been segmented into Germany, France, UK, Italy, Spain, and the Rest of Europe. The market growth in this region is attributed to the rising awareness of the disease diagnosis, increasing ageing population, and technological advancements in in-vitro diagnostics thereby dominating the overall market growth. Germany accounts for the largest share of the in-vitro diagnostic (IVD) market in Europe. The German IVD industry is known for its innovation capabilities. Its IVD industry benefits from developments in molecular biology, miniaturization, and automation. The German “Industrie 4.0” project is undergoing digitalization, particularly in ICD, with “Lab 4.0” developed for data handling, cloud-based IT solutions, lab and production automation processes, and digital networking.
The IVD market in Germany experienced an enormous rise in demand amid the COVID-19 pandemic. Comprehensive testing was a central component of the German government’s health policy strategy to combat the pandemic and protect the population from infection. Companies based in Germany are proven innovators in developing molecular tests as well as high-tech instruments and consumables that are used in the bioanalysis of molecular information. Developments of in-vitro diagnostics through innovative product launches by companies with automation systems in labs boost the in-vitro diagnostics market in Germany.
Europe In-Vitro Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Europe In-Vitro Diagnostics Market Segmentation
The Europe in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.
Based on product & services, the Europe in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the Europe in-vitro diagnostics market in 2022.
Based on technology, the Europe in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the Europe in-vitro diagnostics market in 2022.
Based on application, the Europe in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the Europe in-vitro diagnostics market in 2022.
Based on end user, the Europe in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held the largest share of the Europe in-vitro diagnostics market in 2022.
Based on country, the Europe in-vitro diagnostics market is segmented int o Germany, France, UK, Italy, Spain, and the Rest of Europe. The Rest of Europe dominated the Europe in-vitro diagnostics market in 2022.
Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe in-vitro diagnostics market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to The Research Team’ research, the Europe in-vitro diagnostics market was valued at US$ 22,616.55 million in 2022 and is expected to reach US$ 34,247.12 million by 2030, registering a CAGR of 5.3% from 2022 to 2030. Integration of IVD technologies with digital health solutions and increasing demand for personalized medicine and genomics are among the critical factors attributed to the Europe in-vitro diagnostics market expansion.
IVD is used in clinical, laboratory, and outpatient settings with the aim specifically to help in the detection of diseases and, consequently, aid in the selection of appropriate treatment protocols. The integration of IVD technologies with digital health solutions is gaining traction globally. Data analytics, artificial Intelligence, and remote monitoring enhance the value of diagnostic tests, leading to better patient management and outcomes. IVD technologies integrated with digital health solutions can be incorporated into clinical decision support systems. As recognized by the WHO, digital health solutions could help detect diseases. Artificial intelligence health bots and similar other emerging solutions may present opportunities for patient care and address challenges such as high cost and time requirements. In diagnostics based on genomic testing, deep learning can identify cancer cells, determine their type, and predict what mutations may occur in a tumor from images of a specific sample. Artificial intelligence and machine learning (AI/ML) in in-vitro diagnostics are revolutionizing medical device development. These modern diagnostic systems facilitate diagnosis based on digital image analysis, thereby improving healthcare decision-making. Smart diagnostics are extremely scalable IVD solutions that use artificial intelligence to perform better than lab-based diagnostics at a fraction of the price. Additionally, this type of diagnostics can derive emergent features through unique chemical and biological signature detection and analysis. Thus, the integration of IVD with digital health technologies is likely to offer lucrative opportunities to the in-vitro diagnostics market in the coming years.
On the contrary, cumbersome reimbursement procedures and stringent regulations regarding products hamper the Europe in-vitro diagnostics market.
Based on product & services, the Europe in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held 79.0% share of Europe in-vitro diagnostics market in 2022, amassing US$ 17,873.02 million. It is projected to garner US$ 27,341.94 million by 2030 to expand at 5.5% CAGR during 2022–2030.
Based on technology, the Europe in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held 28.2% share of Europe in-vitro diagnostics market in 2022, amassing US$ 6,371.97 million. It is projected to garner US$ 10,052.27 million by 2030 to expand at 5.9% CAGR during 2022–2030.
Based on application, the Europe in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held 40.0% share of Europe in-vitro diagnostics market in 2022, amassing US$ 9,046.53 million. It is projected to garner US$ 13,955.82 million by 2030 to expand at 5.6% CAGR during 2022–2030.
Based on end user, the Europe in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held 49.0% share of Europe in-vitro diagnostics market in 2022, amassing US$ 11,070.88 million. It is projected to garner US$ 16,329.62 million by 2030 to expand at 5.0% CAGR during 2022–2030.
Based on country, the Europe in-vitro diagnostics market has been categorized into Germany, France, UK, Italy, Spain, and the Rest of Europe. Our regional analysis states that the Rest of Europe captured 23.7% share of Europe in-vitro diagnostics market in 2022. It was assessed at US$ 5,354.12 million in 2022 and is likely to hit US$ 7,705.41 million by 2030, exhibiting a CAGR of 4.7% during 2022–2030.
Key players operating in the Europe in-vitro diagnostics market are Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe In-Vitro Diagnostics Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe In-Vitro Diagnostics Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe In-Vitro Diagnostics Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
4.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
4.2 Market Restraint
4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
4.3 Market Opportunities
4.3.1 Integration of IVD with Digital Health Technologies
4.4 Future Trends
4.4.1 Increasing Demand for Personalized Medicine and Genomics
5. In-Vitro Diagnostics Market – Europe Market Analysis
5.1 Europe In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 – 2030
6. Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services
6.1 Overview
6.2 Europe In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
6.3 Reagents and Kits
6.3.1 Overview
6.3.2 Reagents and Kits: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Software and Services
6.4.1 Overview
6.4.2 Software and Services: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Instruments
6.5.1 Overview
6.5.2 Instruments: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Technology
7.1 Overview
7.2 Europe In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Immunoassay/ Immunochemistry
7.3.1 Overview
7.3.2 Immunoassay/ Immunochemistry: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Clinical Chemistry
7.4.1 Overview
7.4.2 Clinical Chemistry: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Molecular Diagnostics
7.5.1 Overview
7.5.2 Molecular Diagnostics: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Microbiology
7.6.1 Overview
7.6.2 Microbiology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Blood Glucose Self-Monitoring
7.7.1 Overview
7.7.2 Blood Glucose Self-Monitoring: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Coagulation and Hemostasis
7.8.1 Overview
7.8.2 Coagulation and Hemostasis: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Hematology
7.9.1 Overview
7.9.2 Hematology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.10 Urinalysis
7.10.1 Overview
7.10.2 Urinalysis: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Europe In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Infectious Disease
8.3.1 Overview
8.3.2 Infectious Diseases: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Diabetes
8.4.1 Overview
8.4.2 Diabetes: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Oncology
8.5.1 Overview
8.5.2 Oncology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Autoimmune Diseases
8.7.1 Overview
8.7.2 Autoimmune Diseases: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Nephrology
8.8.1 Overview
8.8.2 Nephrology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Europe In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratories
9.4.1 Overview
9.4.2 Laboratories: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Europe In-Vitro Diagnostics Market
10.1.1 Overview
10.1.2 Europe In-Vitro Diagnostics Market, by Country
10.1.2.1 Germany: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Germany: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 Germany: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.1.4 Germany: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.1.5 Germany: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.1.6 Germany: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.2 France: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 France: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 France: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.2.4 France: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.2.5 France: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.2.6 France: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.3 UK: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 UK: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 UK: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.3.4 UK: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.3.5 UK: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.3.6 UK: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.4 Italy: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Italy: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.3 Italy: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.4.4 Italy: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.4.5 Italy: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.4.6 Italy: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.5 Spain: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Spain: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.3 Spain: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.5.4 Spain: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.5.5 Spain: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.5.6 Spain: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.6 Rest of Europe: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.3 Rest of Europe: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.6.4 Rest of Europe: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.6.5 Rest of Europe: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.6.6 Rest of Europe: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11. Industry Landscape
11.1 Organic Developments
11.1.1 Overview
11.2 Inorganic Developments
11.2.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Siemens AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sysmex Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Qiagen NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe In-Vitro Diagnostics Market Segmentation
Table 2. Germany Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 6. France Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 7. France Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. France Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9. France Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. UK Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 11. UK Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 12. UK Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. UK Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Italy Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Italy Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Spain Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 26. Organic Developments Done by Companies
Table 27. Inorganic Developments Done by Companies
Table 28. Glossary of Terms, Europe In-Vitro Diagnostics Market
LIST OF FIGURES
Figure 1. Europe In-Vitro Diagnostics Market Segmentation, By Country
Figure 2. Europe In-Vitro Diagnostics Market: Key Industry Dynamics
Figure 3. Europe In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Europe In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 6. Reagents and Kits: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Software and Services: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Instruments: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 10. Immunoassay/ Immunochemistry: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Clinical Chemistry: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular Diagnostics: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Microbiology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Blood Glucose Self-Monitoring: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Coagulation and Hemostasis: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hematology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Urinalysis: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
Figure 20. Infectious Diseases: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Diabetes: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Oncology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Cardiology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Autoimmune Diseases: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Nephrology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Laboratories: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Homecare: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Europe In-Vitro Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 33. Europe In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 34. Germany: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. France: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. UK: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Italy: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Spain: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Rest of Europe: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
The List of Companies – Europe In-Vitro Diagnostics Market
o Abbott Laboratories
o F. Hoffmann-La Roche Ltd
o Danaher Corp
o Siemens AG
o Sysmex Corp
o Thermo Fisher Scientific Inc
o Becton Dickinson and Co
o bioMerieux SA
o Bio-Rad Laboratories Inc
o Qiagen NV
You must be logged in to post a review.
Reviews
There are no reviews yet.